（文章来源：每日经济新闻） 柳药集团（SH 603368，收盘价：18.54元）8月4日晚间发布公告称，截至2025年7月31日，公司尚未通 过集中竞价交易方式回购公司股份。 2024年1至12月份，柳药集团的营业收入构成为：批发占比78.89%，零售占比15.15%，工业占比 5.49%，其他业务占比0.4%，其他行业占比0.08%。 ...

通过天眼查大数据分析，广西柳药集团股份有限公司共对外投资了26家企业，参与招投标项目1149次， 知识产权方面有商标信息16条，此外企业还拥有行政许可141个。 来源：金融界 天眼查商业履历信息显示，广西柳药集团股份有限公司，成立于1981年，位于柳州市，是一家以从事零 售业为主的企业。企业注册资本39886.3861万人民币，实缴资本14234.8044万人民币。公司法定代表人 为朱朝阳。 金融界消息 截至2025年8月1日收盘，柳药集团（603368）报收于18.69元，上涨3.49%，换手率5.76%， 成交量22.90万手，成交金额4.28亿元。 资金流向方面，今日主力资金净流入3783.45万元，占比成交额8.84%。其中，超大单净流入1726.29万 元、占成交额4.03%，大单净流入2057.16万元、占成交额4.81%，中单净流出流出2452.95万元、占成交 额5.73%，小单净流出1330.50万元、占成交额3.11%。 柳药集团最新一期业绩显示，截至2025一季报，公司营业总收入53.17亿元、同比减少7.93%，归属净利 润2.77亿元，同比减少7.66%，扣非净利润2.72亿元，同比 ...

Group 1 - The company has approved a share repurchase plan using self-owned and self-raised funds through centralized bidding, with a total repurchase amount between RMB 100 million and RMB 200 million, and a maximum repurchase price of RMB 25.70 per share [4][5] - The repurchase period is set to not exceed 12 months from the date of board approval [4] - The company has obtained a loan commitment letter from a financial institution, allowing for a loan of up to RMB 180 million, which can cover up to 90% of the total repurchase funds [5][7] Group 2 - The loan is designated specifically for the purpose of repurchasing company shares and has a maximum term of 3 years [5] - The commitment letter is valid until July 15, 2026, and the actual repurchase amount and quantity will depend on market conditions and the availability of funds [7]

今日焦点 宁德时代：上半年实现净利润305亿元同比增长33.02% 宁德时代公告，上半年实现收入1789亿元，同比增加7.27%；净利润305亿元，同比增长33.02%。报告 期内，本集团实现毛利448亿元，相比2024年同期增加14.45%；综合毛利率为25.02%，相比2024年同期 的23.45%上升1.57个百分点。 上纬新材：多次触及股票交易异常波动和严重异常波动情形明起停牌核查 上纬新材公告称，公司股票自2025年7月9日至7月30日期间多次触及股票交易异常波动及严重异常波动 情形。公司将于7月31日开市起停牌，预计停牌时间不超过3个交易日。公司基本面未发生重大变化，但 股票交易价格已严重脱离基本面，投资者参与交易可能面临较大市场风险。此外，公司股票价格涨幅显 著高于同期相关指数涨幅，换手率显著高于前期水平，市盈率显著高于行业平均水平。公司主营业务和 生产经营未发生重大变化，收购方未来十二个月内不存在资产重组计划，但控制权变更事项仍存在重大 不确定性风险。 金橙子：筹划购买萨米特光电55%股权，股票停牌 金橙子公告称，公司正在筹划以发行股份及支付现金的方式购买长春萨米特光电科技有限公司55%的股 ...

广西柳药集团股份有限公司（以下简称"公司"）于 2025 年 7 月 25 日召开 第五届董事会第二十七次会议，审议通过了《关于以集中竞价交易方式回购股份 方案的议案》。具体内容详见公司于 2025 年 7 月 26 日在上海证券交易所网站 （www.sse.com.cn）披露的《关于以集中竞价交易方式回购股份方案的公告》（公 告编号：2025-053）。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等有关规定，现将公司董事会公告回购股份决议的前一个交 易日（即 2025 年 7 月 25 日）登记在册的前十名股东和前十名无限售条件股东的 名称、持股数量及持股比例情况公告如下： | 序号 | 持有人名称 | 持有数量（股） | 占总股本 比例（%） | | --- | --- | --- | --- | | 1 | 朱朝阳 | 101,032,795 | 25.44 | | 2 | 广东恒健国际投资有限公司 | 10,526,315 | 2.65 | | 陈萍 3 | | 6,151,068 | 1.55 | | 4 | 翟华联 | 5,242,700 | 1.32 ...

| 证券代码：603368 | 证券简称：柳药集团 | 公告编号：2025-055 | | --- | --- | --- | | 转债代码：113563 | 转债简称：柳药转债 | | 一、股份回购方案的基本情况 广西柳药集团股份有限公司（以下简称"公司"）于 2025 年 7 月 25 日召开 第五届董事会第二十七次会议，审议通过了《关于以集中竞价交易方式回购股份 方案的议案》，同意公司使用自有资金和自筹资金通过集中竞价交易方式回购部 分公司 A 股股份，在未来适宜时机用于实施股权激励及/或员工持股计划。本次 回购资金总额不低于人民币 10,000 万元（含），不超过人民币 20,000 万元（含）； 回购价格上限不超过人民币 25.70 元/股（含）；回购期限为自董事会审议通过本 次回购方案之日起不超过 12 个月。具体内容详见公司于 2025 年 7 月 26 日在上 海证券交易所网站（www.sse.com.cn）披露的《关于以集中竞价交易方式回购股 份方案的公告》（公告编号：2025-053）。 二、取得股票回购贷款承诺函的具体情况 近日，公司取得兴业银行股份有限公司柳州分行出具的《贷款承诺函》， ...

格隆汇7月30日丨柳药集团(603368.SH)公布，近日，公司取得兴业银行股份有限公司柳州分行出具的 《贷款承诺函》，主要内容如下：1、贷款额度：不超过人民币1.80亿元，且不超过本次股票回购资金 总额的90%（该比例以最终监管要求为准）；2、贷款期限：不超过3年；3、贷款用途：专项用于回购 公司股份；4、承诺函有效期截止日：2026年7月15日。 ...

Market Overview - The pharmaceutical commercial sector increased by 1.04% on July 30, with Huaren Health leading the gains [1] - The Shanghai Composite Index closed at 3615.72, up 0.17%, while the Shenzhen Component Index closed at 11203.03, down 0.77% [1] Top Performers - Huaren Health (301408) closed at 15.01, up 5.48% with a trading volume of 334,100 shares and a transaction value of 499 million [1] - Jiazhang Tang (002462) closed at 14.67, up 4.19% with a trading volume of 232,300 shares and a transaction value of 346 million [1] - Laobaixing (603883) closed at 19.69, up 2.93% with a trading volume of 398,800 shares and a transaction value of 779 million [1] - China National Pharmaceutical (600056) closed at 11.28, up 2.64% with a trading volume of 656,900 shares and a transaction value of 747 million [1] Underperformers - Renmin Tongtai (600829) closed at 8.77, down 7.20% with a trading volume of 724,400 shares and a transaction value of 651 million [2] - Saily Medical (603716) closed at 30.89, down 2.31% with a trading volume of 444,300 shares and a transaction value of 1.385 billion [2] - Runda Medical (603108) closed at 18.20, down 1.83% with a trading volume of 299,700 shares and a transaction value of 552 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 62.07 million from institutional investors, while retail investors saw a net inflow of 64.93 million [2] - Major stocks like Laobaixing and China National Pharmaceutical had significant net inflows from retail investors, despite overall sector outflows [3] Individual Stock Analysis - Laobaixing (603883) had a net inflow of 62.57 million from institutional investors, but a net outflow of 45.34 million from retail investors [3] - China National Pharmaceutical (600056) saw a net inflow of 49.86 million from institutional investors, with a net outflow of 43.44 million from retail investors [3] - Huaren Health (301408) had a net inflow of 21.02 million from institutional investors, but a net outflow of 26.49 million from retail investors [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603368 证券简称：柳药集团 公告编号：2025-053 转债代码：113563 转债简称：柳药转债 广西柳药集团股份有限公司关于以集中竞价交易方式回购股份方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 广西柳药集团股份有限公司（以下简称"公司"）基于对未来发展前景的信心和对公司长期价值的高度认 可，为推动公司股票价值的合理回归，稳定投资者预期，增强市场信心，维护公司和全体股东的利益， 并进一步落实"提质增效重回报"行动方案，公司拟以集中竞价交易方式回购公司发行的部分人民币普通 股A股股份。主要内容如下： ● 回购股份金额：不低于人民币10,000万元（含），不超过人民币20,000万元（含）。 ● 回购股份资金来源：公司自有资金和自筹资金。 ● 回购股份用途：拟在未来适宜时机用于实施股权激励及/或员工持股计划；若公司未能在本次股份回 购完成后3年内实施上述用途，则未使用的已回购股份将履行相关程序予以注销。 ● 回购股份价格：不超过 ...

Group 1: Company Announcements - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan, including a reconstruction compensation investment of about 2.228 billion yuan [1] - Fushun Special Steel announced that Ningbo Meishan Bonded Port Area Jincheng Shazhou intends to make a partial tender offer to acquire 5% of the company's shares at a price of 5.6 yuan per share [2] - China Duty Free Group reported a net profit of 2.6 billion yuan for the first half of 2025, a year-on-year decrease of 20.81%, with total operating revenue of 28.151 billion yuan, down 9.96% [3] - Gaozheng Mining announced that its controlling shareholder, Cangjian Group, reduced its shareholding by 2.76 million shares, bringing its stake down to 57.6% [4] - Sanfeng Intelligent reported that its director Chen Wei is under investigation, but the company's operations remain normal [5] - Guangsheng Group's innovative hepatitis B treatment drug GST-HG141 has successfully enrolled its first participant in a Phase III clinical trial [6] - Western Gold announced plans to acquire 100% of Xinjiang Meisheng for 1.655 billion yuan, with a premium of 1421.66% over the book value [7] - Huqin Technology announced that shareholders holding more than 5% plan to reduce their holdings by up to 4% of the company's shares [8] - Dongshan Precision's subsidiary plans to invest up to 1 billion USD in a high-end printed circuit board project [10] - Yitian Intelligent plans to jointly invest in a private equity fund focusing on artificial intelligence and computing power, with a total subscription amount of 2 billion yuan [11] - *ST Wanfang is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [12] - Ruibeka and its controlling shareholder are also under investigation by the CSRC for similar reasons [13] - BioShares' subsidiary received clinical trial approval for a cat infectious peritonitis mRNA vaccine [14] - Ruipu Bio received the first clinical trial approval for an mRNA vaccine for economic animals in China [15] - Shengke Communication announced that a major fund plans to reduce its holdings by up to 3% of the company's shares [16] - ShenKai Co. announced a capital increase of 15 million yuan in Shandong Future Robotics, a deep-sea operation robot company [18] - Shouchuang Securities plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance capital strength [19] Group 2: Financial Performance - Western Mining reported a net profit of 1.869 billion yuan for the first half of the year, a year-on-year increase of 15% [20] - Digital Certification expects a loss of 80 million to 96 million yuan for the first half of the year [21] Group 3: Major Contracts and Share Buybacks - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [22] - Zhejiang Communications Technology's subsidiary won two projects totaling over 3.4 billion yuan [23] - Feilong Co. received a notification from SAIC Motor for a designated sales agreement, expecting sales revenue of over 400 million yuan during its lifecycle [24] - Liuyuan Group plans to repurchase shares worth 100 million to 200 million yuan [25] - Meikailong's shareholders plan to reduce their holdings by no more than 3.0011% of the company's shares [26]